| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.0008 |